Navigation Links
Tigermed Sets Up Subsidiary, Hunan Tigermed Xiangya Drug R&D Ltd (Tigermed Xiangya)
Date:12/1/2008

HANGZHOU, China, Dec. 1 /PRNewswire-Asia/ -- Tigermed Consulting Co., Ltd, a leading Contract Research Organization (CRO) in China, announced that it has established a subsidiary, Hunan Tigermed Xiangya Drug R&D Ltd, with Central South University (CSU). The establishment of Tigermed Xiangya marks Tigermed's participation in the construction of a nationwide first-rate Phase I Clinical Laboratory, and further substantiates Tigermed's service ability in drug pre-clinical studies and pharmaceutical analysis. This new cooperation allows Tigermed to provide more extensive and comprehensive outsourcing clinical services for Multinational Pharmaceutical Corporations and Local Research Institutions in the research and development of innovative drugs.

Tigermed, staffed with a team of 100 plus professionals, is dedicated to providing such all-round services as Phase I-IV clinical trials, data management & statistical analysis and regulatory affairs, and Tigermed has accumulated outstanding experience in the clinical trials of innovative drugs. In July 2008, financed by Qiming Ventures, an internationally renowned venture capital organization, Tigermed entered into a period of rapid expansion.

Xiangya Medical College, predecessor of Xiangya Medical School of CSU, was founded in 1914 as one of the early western medicine colleges and universities in China, and enjoyed a high reputation as "South Xiangya, North Union", widely recognizing that Xiangya Medical College in the south and Peking Union Medical College in the north of China are the most two famous medical institutions. Currently, Xiangya Medical School of CSU has three affiliated tertiary hospitals, 8 clinical colleges and 24 stable teaching bases. Phase I Clinical Laboratory of the Drug Clinical Trial Agency in the third Xiangya Hospital of CSU is one of the first groups of Laboratories passing preliminary examination.

Tigermed Xia
'/>"/>

SOURCE China Medicine Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. A Better Tomorrow Treatment Center Inc., Forterus Inc.s Behavioral Healthcare Subsidiary, is the First in the Nation to Offer DNA-Customized Treatment for Individuals with a Genetic Predisposition for Addictive Behavior
2. Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc.
3. Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
4. Viragen Internationals Subsidiary, ViraNative AB, Files to Seek Bankruptcy Protection in Sweden
5. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Calif. , March 2, 2015 ... company developing therapies for autoimmune and infectious diseases, ... (USPTO) has issued an important new composition of ... function through the targeting of CLIP. ... peptide technology underlying VG Life Sciences, VG1177, a ...
(Date:3/2/2015)... 2015 Global Stem Cells ... with Shenzhen HANK Bioengineering Co., Ltd. and its ... will establish a stem cells training course in ... September 2015. , Shenzhen HANK is a biotechnology ... scientist, microbiologist and virologist, to integrate research, development, ...
(Date:3/1/2015)... 01, 2015 Market Publishers Ltd ... quality market research promotion on Internet. MarketPublishers.com is ... worked out by DataGroup Booksellers. , Natalie Aster, ... Ltd, commented on the recent partnership agreement as ... in our team of publishers. Since 1974, the ...
(Date:2/27/2015)... Immunovaccine Inc. (“Immunovaccine” or the “Company”) (TSX: ... release disseminated this morning by PR Web, and redistributed ... release states that Immunovaccine has entered into a co-development ... did not originate from Immunovaccine and there is no ... Please note that all official statements by Immunovaccine ...
Breaking Biology Technology:VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 2Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 3Immunovaccine Disclaims Hoax Press Release 2
... will be unlike any other in the Midwest. Only five ... them in the Midwest region, said Terrence R. Dolan, PhD, ... square feet of laboratory space, the factory will be an ... reveal that there is a growing list of global clients ...
... common stock of Bruker AXS will be converted into the ... Bruker Daltonics or, at the election of each Bruker AXS ... in Bruker Daltonics common stock and 25% in cash. Shares ... changed in the merger. , ,The combined company, expected to ...
... me to name a few fields in which todays Wisconsin ... education. The real answer is: I dont know. And if ... in those industries and gleefully count my earnings. , ,But ... jobs for tomorrow deserves far more than a glib answer. ...
Cached Biology Technology:Biotech Manufacturing Facility to be Built in Wisconsin 2Bruker Daltonics and Bruker AXS Announce Merger Agreement 2Heres how todays Wisconsin children will find jobs tomorrow 2Heres how todays Wisconsin children will find jobs tomorrow 3
(Date:1/22/2015)...  A man-made form of insulin delivered by nasal spray ... adults with mild cognitive impairment and Alzheimer,s disease dementia, ... Wake Forest Baptist Medical Center. The study,s ... impairment (MCI) or mild to moderate Alzheimer,s dementia (AD). ...
(Date:1/22/2015)... Washington , January 20, 2015 Investorideas.com, ... tech stocks, releases video from the CES 2015 (Consumer Electronics ... Apollo Robbins . Apollo shows how easily ... smart wallet, a product of NXT-ID, Inc. (NASDAQ: ...
(Date:1/22/2015)... , January 22, 2015 , ... year  The European Patent Office to present a video ... British nominations to be featured: Christofer Toumazou and ... former finalists and winners of the Award   Starting ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3
... Cancer Epidemiology, Biomarkers & Prevention , a journal of the ... that fish oil supplements may play a role in preventing ... Research Center in Seattle, Wash., led by Emily White, Ph.D., ... postmenopausal women who did not have a history of breast ...
... from which maize (corn) evolved, might be forgiven for assuming ... the other. However, a method for exploring the genetics ... that only modest modifications are needed to convert a wild ... can even be achieved by a single genetic change. ...
... Although global grain production must double by 2050 to ... University of Illinois suggests crop yields will suffer unless ... are adopted. Improved agronomic traits responsible for the remarkable ... have reached their ceiling for some of the world,s ...
Cached Biology News:Fish oil may reduce risk of breast cancer 2What plant genes tell us about crop domestication 2What plant genes tell us about crop domestication 3What plant genes tell us about crop domestication 4What plant genes tell us about crop domestication 5'Business as usual' crop development won't satisfy future demand 2'Business as usual' crop development won't satisfy future demand 3
Anti human PPAR gamma2 mouse monoclonal antibody...
Anti-Potassium Channel Kv2.2 Immunogen: Synthetic peptide from rat Kv2.2. Available Date: 38376...
Mouse monoclonal [1241] to Parainfluenza Virus type 2...
Mouse monoclonal [1C6/2] to Rad17 ( Abpromise for all tested applications). entrezGeneID: 5884 SwissProtID: Q9UPF5...
Biology Products: